CpG motifs in bacterial DNA trigger direct B-cell activation
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Unmethylated CpG dinucleotides are more frequent in the genomes of bacteria and viruses than of vertebrates. We report here that bacterial DNA and synthetic oligodeoxynucleotides containing unmethylated CpG dinucleotides induce murine B cells to proliferate and secrete immunoglobulin in vitro and in vivo. This activation is enhanced by simultaneous signals delivered through the antigen receptor. Optimal B-cell activation requires a DNA motif in which an unmethylated CpG dinucleotide is flanked by two 5' purines and two 3' pyrimidines. Oligodeoxynucleotides containing this CpG motif induce more than 95% of all spleen B cells to enter the cell cycle. These data suggest a possible evolutionary link between immune defence based on the recognition of microbial DNA and the phenomenon of 'CpG suppression' in vertebrates. The potent immune activation by CpG oligonucleotides has implications for the design and interpretation of studies using 'antisense' oligonucleotides and points to possible new applications as adjuvants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unmethylated CpG motifs in bacterial DNA are potent triggers of inflammation (Klinman et al., 1997; Krieg et al., 1995).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Krieg et al., 1995
In the citing paper
“CpG DNA is a potent stimulator of TLR9 (12).”
From Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice (2011) · cites this paper as [12]
Citations
Cites
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
Gene inhibition using antisense oligodeoxynucleotides
Wagner, R. W. (1994) · Nature · doi:10.1038/372333a0 · Cited by 736
CpG islands as gene markers in the vertebrate nucleus
Bird, A. P. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90294-0 · Cited by 678
Current concepts in antisense drug design
Milligan, J. F., Matteucci, M. D., & Martin, J. C. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00066a001 · Cited by 566
Richardson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S., & Johnson, M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331109 · Cited by 562
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Agrawal, S., Temsamani, J., & Tang, J. Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7595 · Cited by 561
Therapeutic Applications of Oligonucleotides
Crooke, S. T. (1992) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.32.040192.001553 · Cited by 446
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
Messina, J. P., Gilkeson, G. S., & Pisetsky, D. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.6.1759 · Cited by 371
Lymphocyte stimulation: a rapid multiparameter analysis.
Darzynkiewicz, Z., Traganos, F., Sharpless, T., & Melamed, M. R. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.8.2881 · Cited by 347
Frequency of B lymphocytes responsive to anti-immunoglobulin.
Defranco, A. L., Raveche, E. S., Asofsky, R., & Paul, W. E. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.5.1523 · Cited by 293
Research works printed but not linked: 1
- Krapf, F., Herrmann, M., Leitmann, W. & Kalden, J. R. Clin. exp. immun. 75, 336–342 (1989).
Cited by
Items 701–800 of 1,013
Cai, H., Shukla, S., & Steinmetz, N. F. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201908743 · Cited by 92
Gong, Y.-F., Xiang, L., & Shao, J.-Z. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804370 · Cited by 90
Peter, M. E., Kubarenko, A. V., Weber, A. N. R., & Dalpke, A. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900819 · Cited by 90
Henry, S. P., Templin, M. V., Gillett, N. A., Rojko, J. L., & Levin, A. A. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700117 · Cited by 90
CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells
Gürsel, M., Verthelyi, D. I., & Klinman, D. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200209)32:9<2617::aid-immu2617>3.0.co;2-f · Cited by 90
Self-citationNatural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation
Lai, C.-Y., Su, Y.-W., Lin, K.-I., Hsu, L.-C., & Chuang, T.-H. (2017) · Journal of Immunology Research · doi:10.1155/2017/7807313 · Cited by 88
Schmitz, F., Mages, J., Heit, A., Lang, R., & Wagner, H. (2004) · European Journal of Immunology · doi:10.1002/eji.200425228 · Cited by 96
Mui, B., Raney, S. G., Semple, S. C., & Hope, M. J. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29491-x · Cited by 88
Therapeutic Applications of CpG-Containing Oligodeoxynucleotides
Klinman, D. M. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.181 · Cited by 94
Self-citationRedford, T. W., Yi, A., Ward, C. T., & Krieg, A. Μ. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3930 · Cited by 98
Self-citationPattern Recognition by Toll-like Receptors
Bauer, S., Müller, T. R., & Hamm, S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0901-5_2 · Cited by 101
Monocyte and macrophage heterogeneity and Toll-like receptors in the lung
Schneberger, D., Aharonson-Raz, K., & Singh, B. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1032-2 · Cited by 108
Yu, D. S., Kandimalla, E. R., Roskey, A., Zhao, Q., Chen, L., Chen, J., & Agrawal, S. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00275-8 · Cited by 100
TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines
Tudor, D., Dubuquoy, C., Gaboriau‐Routhiau, V., Lefèvre, F., Charley, B., & Riffault, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.09.001 · Cited by 88
Amos, S. M., Pegram, H. J., Westwood, J. A., John, L. B., Devaud, C., Clarke, C. J., Restifo, N. P., Smyth, M. J., Darcy, P. K., & Kershaw, M. H. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-0984-8 · Cited by 88
Kumar, S., Jones, T. R., Oakley, M. S., Zheng, H., Kuppusamy, S. P., Taye, A., Krieg, A. Μ., Stowers, A. W., Kaslow, D. C., & Hoffman, S. L. (2004) · Infection and Immunity · doi:10.1128/iai.72.2.949-957.2004 · Cited by 94
Self-citationCpG oligodeoxynucleotides activate grass carp (Ctenopharyngodon idellus) macrophages
Meng, Z., Shao, J., & Xiang, L. (2003) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(02)00104-0 · Cited by 88
Stoicov, C., Saffari, R., Cai, X., Hasyagar, C. P., & Houghton, J. (2004) · Gene · doi:10.1016/j.gene.2004.07.023 · Cited by 100
DNA vaccines: safety and efficacy issues
Klinman, D. M., Takeno, M., Ichino, M., Gu, M., Yamshchikov, G. V., Mor, G., & Conover, J. (1997) · Springer Seminars in Immunopathology · doi:10.1007/bf00870272 · Cited by 102
Self-citationTargeting c-Myb expression in human disease
Ramsay, R. G., Barton, A. L., & Gonda, T. J. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.2.235 · Cited by 88
Hartmann, G., Krug, A., Waller-Fontaine, K., & Endres, S. (1996) · Molecular Medicine · doi:10.1007/bf03401902 · Cited by 89
Mortaz, E., Henricks, P. A. J., Kraneveld, A. D., Givi, M. E., Garssen, J., & Folkerts, G. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.002 · Cited by 87
Wen, Z., Xu, W., Xu, L., Cao, Q. H., Wang, Y., Chu, Y., & Xiong, S. (2007) · Rheumatology · doi:10.1093/rheumatology/kem275 · Cited by 87
Eaton-Bassiri, A., Dillon, S. B., Cunningham, M., Rycyzyn, M. A., Mills, J., Sarisky, R. T., & Mbow, M. L. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7202-7211.2004 · Cited by 90
Cazorla, S. I., Becker, P. D., Frank, F. M., Ebensen, T., Sartori, M. J., Corral, R. S., Malchiodi, E. L., & Guzmán, C. A. (2007) · Infection and Immunity · doi:10.1128/iai.01163-07 · Cited by 87
Direct and indirect role of Toll-like receptors in T cell mediated immunity.
DamoXu, HaiyingLiu, & MousaKomai-Koma (2004) · PubMed · Cited by 98
Oxidative damage to 5-methylcytosine in DNA
Zuo, S., Boorstein, R. J., & Teebor, G. W. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.16.3239 · Cited by 87
Toll-like receptor signaling in anti-cancer immunity.
Okamoto, M., & Sato, M. (2003) · PubMed · Cited by 94
IFN-γ Primes Macrophage Responses to Bacterial DNA
Sweet, M. J., Stacey, K. J., Kakuda, D. K., Markovich, D., & Hume, D. A. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.263 · Cited by 100
Distinct CpG oligonucleotide sequences activate human γ δ T cells via interferon-α/-β
Rothenfußer, S., Hornung, V., Krug, A., Towarowski, A., Krieg, A. Μ., Endres, S., & Hartmann, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200112)31:12<3525::aid-immu3525>3.0.co;2-5 · Cited by 87
Self-citationThe Mechanisms of Pharmacological Activities of Ophiocordyceps sinensis Fungi
Xu, J. L., Huang, Y., Chen, X.-X., Zheng, S., Chen, P., & Mo, M. (2016) · Phytotherapy Research · doi:10.1002/ptr.5673 · Cited by 89
DNA Sensing across the Tree of Life
Gallucci, S., & Maffei, M. E. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.07.012 · Cited by 90
Schaefer, M., Reiling, N., Fessler, C., Stephani, J., Taniuchi, I., Hatam, F., Yildirim, A. Ö., Fehrenbach, H., Walter, K., Ruland, J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6836 · Cited by 91
Lammers, K. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i46.7323 · Cited by 86
Ho, P. P., Fontoura, P., Ruiz, P. J., Steinman, L., & Garren, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4920 · Cited by 85
Th1-Like Cytokine Induction by Heat-Killed Brucella abortus Is Dependent on Triggering of TLR9
Huang, L., Ishii, K. J., Akira, S., Aliberti, J., & Golding, B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3964 · Cited by 86
Possible mechanisms underlying age‐related resistance to bovine babesiosis
Zintl, A., Gray, J., Skerrett, H. E., & Mulcahy, G. M. (2005) · Parasite Immunology · doi:10.1111/j.1365-3024.2005.00748.x · Cited by 86
Gomis, S. M., Babiuk, L. A., Allan, B. J., Willson, P. J., Waters, E., Ambrose, N., Hecker, R., & Potter, A. A. (2004) · Avian Diseases · doi:10.1637/7194-041204r · Cited by 86
Mohsen, M. O., Gomes, A. C., Cabral‐Miranda, G., Krueger, C. C., Leoratti, F. M. S., Stein, J. V., & Bachmann, M. F. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.031 · Cited by 86
Fu, T., Guan, L., Friedman, A., Schofield, T. L., Ulmer, J. B., Liu, M. A., & Donnelly, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4163 · Cited by 86
Gao, J. J., Xue, Q., Papasian, C. J., & Morrison, D. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6855 · Cited by 86
Zhao, H., Hemmi, H., Akira, S., Cheng, S. H., Scheule, R. K., & Yew, N. S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.012 · Cited by 85
An overview of in silico vaccine design against different pathogens and cancer
Kardani, K., Bolhassani, A., & Namvar, A. (2020) · Expert Review of Vaccines · doi:10.1080/14760584.2020.1794832 · Cited by 96
Hayashi, E. A., Akira, S., & Nóbrega, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6639 · Cited by 88
Fogg, C. N., Americo, J. L., Lustig, S., Huggins, J. W., Smith, S. K., Damon, I. K., Resch, W., Earl, P. L., Klinman, D. M., & Moss, B. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.12.037 · Cited by 85
Self-citationSchaffert, D. H., Kiss, M., Rödl, W., Shir, A., Levitzki, A., Ogris, M., & Wagner, E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0225-4 · Cited by 97
Iliev, I. D., Kitazawa, H., Shimosato, T., Katoh, S., Morita, H., He, F., Hosoda, M., & Saito, T. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00470.x · Cited by 86
Reduction of Antigen Expression from DNA Vaccines by Coadministered Oligodeoxynucleotides
Weeratna, R. D., Millan, C. L. B., Krieg, A. Μ., & Davis, H. L. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.351 · Cited by 85
Self-citationGerber, S., Lane, C., Brown, D. M., Lord, E. M., DiLorenzo, M., Clements, J. D., Rybicki, E. P., Williamson, A., & Rose, R. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4752-4760.2001 · Cited by 85
Gramzinski, R. A., Millan, C. L. B., Obaldía, N., Hoffman, S. L., & Davis, H. L. (1998) · Molecular Medicine · doi:10.1007/bf03401734 · Cited by 85
Induction of type I IFNs by intracellular DNA‐sensing pathways
Cavlar, T., Ablasser, A., & Hornung, V. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2012.11 · Cited by 84
Atypical p-ANCA in PSC and AIH: A Hint Toward a “leaky gut”?
Terjung, B., & Spengler, U. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8088-8 · Cited by 93
Bromidge, S. M., Duckworth, M. D., Forbes, I. T., Ham, P., King, F. D., Thewlis, K. M., Blaney, F. E., Naylor, C. B., Blackburn, T. P., Kennett, G. A., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970424c · Cited by 84
New technologies for making vaccines
Ellis, R. W. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00416-2 · Cited by 84
Chu, R. S., McCool, T. L., Greenspan, N. S., Schreiber, J. R., & Harding, C. V. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1450-1456.2000 · Cited by 84
Leutenegger, C. M., Boretti, F. S., Mislin, C. N., Flynn, J. N., Schroff, M., Habel, A., Junghans, C., König-Merediz, S. A., Sigrist, B., Aubert, A., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10447-10457.2000 · Cited by 84
Douagi, I., Gujer, C., Sundling, C., Adams, W. C. T., Smed‐Sörensen, A., Seder, R. A., Hedestam, G. B. K., & Loré, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802257 · Cited by 84
Hurtado, P. R., & Peh, C. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902305 · Cited by 102
Bacterial ghosts as adjuvant particles
Riedmann, E. M., Kyd, J. M., Cripps, A. W., & Lubitz, W. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.2.241 · Cited by 89
CpG DNA-mediated immune response in pulmonary endothelial cells
Li, J., Ma, Z., Tang, Z.-L., Stevens, T., Pitt, B., & Li, S. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00436.2003 · Cited by 83
Necessity of Oligonucleotide Aggregation for Toll-like Receptor 9 Activation
Wu, C. C. N., Lee, J., Raz, E., Corr, M., & Carson, D. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311662200 · Cited by 84
Medicinal chemistry and therapeutic potential of CpG DNA
Agrawal, S., & Kandimalla, E. R. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02264-x · Cited by 83
Fournié, G. J., Mas, M., Cautain, B., Savignac, M., Subra, J., Pelletier, L., Saoudi, A., Lagrange, D., Calise, M., & Druet, P. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0482 · Cited by 83
Effects of adjuvants on IgG subclasses elicited by virus-like Particles
Visciano, M. L., Tagliamonte, M., Tornesello, M. L., Buonaguro, L., & Buonaguro, L. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-4 · Cited by 82
Casulleras, M., Flores‐Costa, R., Duran‐Güell, M., Alcaraz‐Quiles, J., Sanz, S., Titos, E., López‐Vicario, C., Fernández, J., Horrillo, R., Costa, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax5135 · Cited by 88
Welner, R. S., Pelayo, R., Garrett, K. P., Chen, X., Perry, S. S., Sun, X.-H., Kee, B. L., & Kincade, P. W. (2007) · Blood · doi:10.1182/blood-2006-08-043810 · Cited by 86
Sagiv-Barfi, I., Kohrt, H. E., Burckhardt, L., Czerwinski, D. K., & Levy, R. (2015) · Blood · doi:10.1182/blood-2014-08-593137 · Cited by 83
Samulowitz, U., Weber, M., Weeratna, R. D., Uhlmann, E., Noll, B. O., Krieg, A. Μ., & Vollmer, J. (2010) · Oligonucleotides · doi:10.1089/oli.2009.0210 · Cited by 82
Self-citationDurieux, A., Bonnefoy, R., Busso, T., & Freyssenet, D. G. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.534 · Cited by 85
CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo
Knuefermann, P., Baumgarten, G., Koch, A. H., Schwederski, M., Velten, M., Ehrentraut, H., Mersmann, J., Meyer, R., Hoeft, A., Zacharowski, K. D., et al. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-72 · Cited by 95
BAFF costimulation of Toll‐like receptor‐activatedB‐1 cells
Ng, L. G., Ng, C., Woehl, B., Sutherland, A. P. R., Huo, J., Xu, S., Mackay, F., & Lam, K. (2006) · European Journal of Immunology · doi:10.1002/eji.200635956 · Cited by 82
Antisense DNAs as multisite genomic modulators identified by DNA microarray
Cho, Y. S., Kim, M.-K., Cheadle, C., Neary, C. L., Becker, K. G., & Cho‐Chung, Y. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171314398 · Cited by 82
Herpes Simplex Virus Type 1 DNA Is Immunostimulatory In Vitro and In Vivo
Lundberg, P. S., Welander, P. V., Han, X., & Cantin, E. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11158-11169.2003 · Cited by 82
DNA vaccines for viral diseases
Davis, H. L., & McCluskie, M. J. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)80009-4 · Cited by 94
APC Stimulated by CpG Oligodeoxynucleotide Enhance Activation of MHC Class I-Restricted T Cells
Warren, T. L., Bhatia, S. K., Acosta, A. M., Dahle, C. E., Ratliff, T. L., Krieg, A. Μ., & Weiner, G. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6244 · Cited by 82
Self-citationMechanisms and therapeutic applications of immune stimulatory CpG DNA
KRIEG, A. M. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00023-6 · Cited by 82
Self-citationCui, Z., & Qiu, F. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0114-6 · Cited by 91
A DNA/DMXAA/Metal–Organic Framework Activator of Innate Immunity for Boosting Anticancer Immunity
Chen, X., Tang, Q., Wang, J., Zhou, Y., Li, F., Xie, Y., Wang, X., Du, L., Li, J., Pu, J., et al. (2023) · Advanced Materials · doi:10.1002/adma.202210440 · Cited by 97
Kim, T., Myoung, H.-J., Kim, J., Moon, I. S., Kim, T., Ahn, W., & Sin, J. (2002) · PubMed · Cited by 83
Jurk, M., & Vollmer, J. (2007) · BioDrugs · doi:10.2165/00063030-200721060-00006 · Cited by 89
Gu, M., Ma, H., Mai, K., Zhang, W., Ai, Q., Wang, X., & Bai, N. (2010) · Aquaculture · doi:10.1016/j.aquaculture.2010.05.024 · Cited by 81
DNA vaccination by immersion and ultrasound to trout viral haemorrhagic septicaemia virus
Fernández‐Alonso, M., Rocha, A., & Coll, J. M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00046-9 · Cited by 81
Mukherjee, P., Pathangey, L. B., Bradley, J. B., Tinder, T. L., Basu, G. D., Akporiaye, E. T., & Gendler, S. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.11.007 · Cited by 81
Mastelic, B., Kamath, A. T., Fontannaz, P., Tougne, C., Rochat, A., Belnoue, E., Combescure, C., Auderset, F., Lambert, P., Tacchini‐Cottier, F., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201143 · Cited by 87
Knuefermann, P., Schwederski, M., Velten, M., Krings, P., Ehrentraut, H., Rüdiger, M., Boehm, O., Fink, K., Dreiner, U., Grohé, C., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn011 · Cited by 90
Hirai, M., Kadowaki, N., Kitawaki, T., Fujita, H., Takaori‐Kondo, A., Fukui, R., Miyake, K., Maeda, T., Kamihira, S., Miyachi, Y., et al. (2010) · Blood · doi:10.1182/blood-2010-05-284737 · Cited by 88
Jacob, N., Guo, S., Mathian, A., Koss, M. N., Gindea, S., Putterman, C., Jacob, C. O., & Stohl, W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000466 · Cited by 81
Rapid Response of Marginal Zone B Cells to Viral Particles
Gatto, D., Ruedl, C., Odermatt, B. F., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4308 · Cited by 86
Sun, S., Cai, Z., Langlade‐Demoyen, P., Kosaka, H., Brunmark, A. B., Jackson, M. R., Peterson, P. A., & Sprent, J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80482-3 · Cited by 82
Yi, A., Peckham, D. W., Ashman, R. F., & Krieg, A. Μ. (1999) · International Immunology · doi:10.1093/intimm/11.12.2015 · Cited by 91
Self-citationPlatelet Innate Immune Receptors and TLRs: A Double-Edged Sword
Ebermeyer, T., Cognasse, F., Berthelot, P., Mismetti, P., Garraud, O., & Hamzeh‐Cognasse, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157894 · Cited by 86
Activation of Dendritic Cells by Toll-Like Receptors and C-Type Lectins
Diebold, S. S. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-71029-5_1 · Cited by 99
Advances in Toll-like receptor biology: Modes of activation by diverse stimuli
Bryant, C. E., Gay, N. J., Heymans, S. R. B., Sacre, S. M., Schaefer, L., & Midwood, K. S. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1033511 · Cited by 97
Adjuvants for Leishmania vaccines: from models to clinical application
Raman, V. S., Duthie, M. S., Fox, C. B., Matlashewski, G., & Reed, S. G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00144 · Cited by 89
Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models
Yu, J. M., Heck, S., & Yazdanbakhsh, K. (2007) · American Journal of Hematology · doi:10.1002/ajh.20959 · Cited by 83
Clinical investigations of Toll-like receptor agonists
Meyer, T., & Stockfleth, E. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.7.1051 · Cited by 82
Role of B cells in common variable immune deficiency
Ahn, S. S., & Cunningham‐Rundles, C. (2009) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.43 · Cited by 80
Antibody-Antisense Oligonucleotide Conjugate Downregulates a Key Gene in Glioblastoma Stem Cells
Arnold, A. E., Malek-Adamian, E., Le, P. U., Meng, A., Martínez‐Montero, S., Petrecca, K., Damha, M. J., & Shoichet, M. S. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.04.004 · Cited by 84
'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents
Yu, D. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf582 · Cited by 81
Mixed Backbone Oligonucleotides: Improvement in Oligonucleotide-induced Toxicity In Vivo
Agrawal, S., & Zhao, Q. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.135 · Cited by 83
Metadata
- Authors
- Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M.
- Affiliations
- University of Iowa (US)
- Center for Biologics Evaluation and Research (US)
- ORCID
- Venue
- Nature
- Published
- 1995-04
- Volume
- 374
- Issue
- 6522
- Pages
- 546-549
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2047366876
- Cited by
- 3,508
- References
- 28
- Citations by year
- 2026: 24 · 2025: 36 · 2024: 47 · 2023: 43 · 2022: 58 · 2021: 58 · 2020: 84 · 2019: 84 · 2018: 58 · 2017: 69 · 2016: 76 · 2015: 89 · 2014: 83 · 2013: 102 · 2012: 104
- FWCI
- 36.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- CpG motifs, bacterial DNA, B cell activation, B cell proliferation, immunoglobulin secretion, antigen receptor signaling, CpG oligodeoxynucleotides, CpG suppression, antisense oligonucleotides, adjuvants
- MeSH terms
- Animals, B-Lymphocytes, Base Sequence, Cell Line, DNA, Bacterial, Escherichia coli, Lymphocyte Activation, Methylation, Mice, Inbred DBA, Molecular Sequence Data, Oligodeoxyribonucleotides, T-Lymphocytes, Dinucleoside Phosphates, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.